SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001104659-12-074384
Filing Date
2012-11-06
Accepted
2012-11-06 06:05:11
Documents
12
Period of Report
2012-09-30
Filing Date Changed
2012-11-06

Document Format Files

Seq Description Document Type Size
1 10-Q a12-20042_110q.htm 10-Q 867517
2 EX-31.1 a12-20042_1ex31d1.htm EX-31.1 11927
3 EX-31.2 a12-20042_1ex31d2.htm EX-31.2 12362
4 EX-32.1 a12-20042_1ex32d1.htm EX-32.1 8868
11 GRAPHIC g200421bki001.gif GRAPHIC 8753
12 GRAPHIC g200421bii001.gif GRAPHIC 9234
  Complete submission text file 0001104659-12-074384.txt   5463055

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snta-20120930.xml EX-101.INS 723335
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20120930.xsd EX-101.SCH 40226
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20120930_cal.xml EX-101.CAL 50395
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20120930_lab.xml EX-101.LAB 670239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20120930_pre.xml EX-101.PRE 306998
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20120930_def.xml EX-101.DEF 218024
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 121181653
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1